Company profile for ImaginAb

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ImaginAb is an emerging immune-oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patient’s health—enabling better patient selection & treatment monitoring for immuno-oncology therapies & other drugs.Harnessing the specificity of monoclonal antibodies, ImaginAb designs and engineers small, highly targeted proteins known as minibodies that image important mo...
ImaginAb is an emerging immune-oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patient’s health—enabling better patient selection & treatment monitoring for immuno-oncology therapies & other drugs.Harnessing the specificity of monoclonal antibodies, ImaginAb designs and engineers small, highly targeted proteins known as minibodies that image important molecular targets using standard Positron Emission Tomography (PET).Our imaging tools help physicians answer important clinical questions, improving the path of care & ultimately helping patients lives.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
423 Hindry Ave. Suite D Inglewood, CA 90301
Telephone
Telephone
+1.310.645.1211
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/imaginab-inc-innovative-biologics-technology-platform-acquired-by-telix-to-enable-next-generation-therapeutic-assets-discovery-302357703.html

PR NEWSWIRE
22 Jan 2025

https://www.prnewswire.com/news-releases/telix-to-acquire-next-generation-therapeutic-assets-and-innovative-biologics-technology-platform-302348701.html

PR NEWSWIRE
12 Jan 2025

http://www.pharmabiz.com/NewsDetails.aspx?aid=158199&sid=2

PHARMABIZ
19 May 2023

https://www.prnewswire.com/news-releases/imaginab-advances-two-solid-tumor-radiopharmaceutical-therapy-rpt-candidates-towards-clinical-development-301827696.html

PR NEWSWIRE
18 May 2023

https://www.prnewswire.com/news-releases/imaginab-and-quibim-partner-to-revolutionize-immune-status-diagnosis-and-immunotherapy-prediction-301812551.html

PR NEWSWIRE
02 May 2023

https://www.prnewswire.com/news-releases/imaginab-executes-new-license-and-supply-agreement-for-cd8-immunopet-technology-with-leucid-bio-301794931.html

PR NEWSWIRE
12 Apr 2023

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty